United States Government Publishing Office publisher pbl distributor dst United States National Archives and Records Administration Office of the Federal Register author aut Government Organization text government publication eng FR Regulatory Information 2014_register executive 2014-03-06 article Notices D09002ee1c7fa5a80 D09002ee1c7fa5ab6 United States Department of Health and Human Services originator org United States Government Agency or Subagency United States National Institutes of Health originator org United States Government Agency or Subagency This is notice, in accordance with 35 U.S.C. 209 and 37 CFR 404, that the National Institutes of Health (NIH), Department of Health and Human Services (HHS), is contemplating the grant of a worldwide exclusive evaluation option license to practice the inventions embodied in: HHS Ref. No. E-553-2013/0, U.S. Provisional Patent Application No. 61/863,071, filed August 7, 2013; International Patent Application PCT/ US2013/072344 filed November 27, 2013 entitled "Transvascular And Transcameral Device Access And Closure," to Mehr Medical LLC, having its principle place of business in Andover Massachusetts. The contemplated exclusive license may be limited to caval-aortic devices for aortic valve replacement. Upon the expiration or termination of the start-up exclusive evaluation license, Mehr will have the right to execute a start-up exclusive patent commercialization license with no greater field of use and territory than granted in the evaluation license. 79 FR 12696 https://www.govinfo.gov/app/details/FR-2014-03-06/2014-04928 2014-04928 fr06mr14-29 4140-01-P https://www.govinfo.gov/app/details/FR-2014-03-06/2014-04928 https://www.govinfo.gov/content/pkg/FR-2014-03-06/html/2014-04928.htm https://www.govinfo.gov/content/pkg/FR-2014-03-06/pdf/2014-04928.pdf 2 p. 12696 12697 79 FR 12696 Prospective Grant of Start-Up Exclusive Evaluation License: Caval-Aortic Devices for Aortic Valve Replacement; Federal Register Vol. 79, Issue NOTICE 2014-04928 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health 2014-03-21 4140-01-P 2014-04928 Notice.

This is notice, in accordance with 35 U.S.C. 209 and 37 CFR 404, that the National Institutes of Health (NIH), Department of Health and Human Services (HHS), is contemplating the grant of a worldwide exclusive evaluation option license to practice the inventions embodied in: HHS Ref. No. E-553-2013/0, U.S. Provisional Patent Application No. 61/863,071, filed August 7, 2013; International Patent Application PCT/ US2013/072344 filed November 27, 2013 entitled "Transvascular And Transcameral Device Access And Closure," to Mehr Medical LLC, having its principle place of business in Andover Massachusetts. The contemplated exclusive license may be limited to caval-aortic devices for aortic valve replacement. Upon the expiration or termination of the start-up exclusive evaluation license, Mehr will have the right to execute a start-up exclusive patent commercialization license with no greater field of use and territory than granted in the evaluation license.

Only written comments and/or applications for a license that are received by the NIH Office of Technology Transfer on or before March 21, 2014 will be considered. Exclusive Evaluation Licenses: Caval-Aortic Devices for Aortic Valve Replacement , shmilovm@mail.nih.gov Vol. 79, no. 44 Office of the Federal Register, National Archives and Records Administration 2014-03-06 continuing daily deposited born digital 272 p. Table of Contents: AE 2.7: GS 4.107: AE 2.106: KF70.A2 https://www.govinfo.gov/app/details/FR-2014-03-06 P0b002ee187933632 0097-6326 0042-1219 0364-1406 769-004-00000-9 000582072 f:fr06mr14 https://www.govinfo.gov/app/details/FR-2014-03-06 https://www.govinfo.gov/content/pkg/FR-2014-03-06/pdf/FR-2014-03-06.pdf https://www.govinfo.gov/content/pkg/FR-2014-03-06/xml/FR-2014-03-06.xml fdlp 12655 12921 DGPO 2014-03-06 2024-06-03 FR-2014-03-06 machine generated eng FR FR-2014-03-06 79 44